Industrial Microbiology Global Market Report 2026

Industrial microbiology is a branch of applied microbiology that focuses on the study and practical application of microorganisms. It involves the utilization of microbes for the production of various products.

The primary products within the field of industrial microbiology include equipment and systems, reaction consumables, and laboratory supplies. Equipment and systems encompass various assemblies and components used in industrial microbiology processes. These tools are employed in the manufacturing of key substances such as vaccines, food products, enzymes, and other items. Industrial microbiology equipment and systems are integral in performing tests such as sterility testing, microbial limits testing, bio-burden testing, water and environmental testing. These tests find applications in diverse industries such as food and beverages, pharmaceutical biotechnology, agriculture, environmental science, cosmetics, personal care, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the industrial microbiology market by increasing costs of imported laboratory equipment, automated systems, reagents, and specialized consumables used in microbial testing and production. Pharmaceutical, food, and environmental testing laboratories in North America and Europe are most affected due to reliance on imported instruments, while Asia-Pacific faces cost pressure on consumable supplies. These tariffs are raising operational costs and procurement budgets. However, they are also supporting domestic equipment manufacturing, regional reagent production, and localized laboratory supply chains.

The industrial microbiology market research report is one of a series of new reports from The Business Research Company that provides industrial microbiology market statistics, including industrial microbiology industry global market size, regional shares, competitors with a industrial microbiology market share, detailed industrial microbiology market segments, market trends and opportunities, and any further data you may need to thrive in the industrial microbiology industry. This industrial microbiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The industrial microbiology market size has grown strongly in recent years. It will grow from $16.53 billion in 2025 to $17.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing use of microbes in industrial production, expansion of food and beverage safety testing, rising pharmaceutical manufacturing activity, growing environmental monitoring needs, availability of standardized microbiology equipment.

The industrial microbiology market size is expected to see strong growth in the next few years. It will grow to $24.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing demand for bio-based industrial products, rising adoption of automation in laboratories, expansion of biopharmaceutical manufacturing, growing focus on sustainable production processes, increasing regulatory emphasis on microbial quality control. Major trends in the forecast period include increasing adoption of automated microbial testing systems, rising demand for industrial fermentation applications, growing focus on sustainable bio-based production, expansion of microbial quality testing services, enhanced use of data analytics in microbiology.

Rising pharmaceutical production is expected to drive the expansion of the industrial microbiology market in the coming years. Pharmaceutical production refers to the manufacture of medicines and therapeutic products through chemical synthesis, biological methods, or biopharmaceutical techniques. The growth in pharmaceutical production can be linked to several factors, such as an aging population, regulatory developments, and health crises that increase the demand for medications and innovative therapies. Industrial microbiology utilizes microbial fermentation processes to produce pharmaceuticals on a large scale, including antibiotics such as penicillin, vaccines, and hormones like insulin, by using microorganisms such as bacteria, yeast, and fungi. For example, in April 2025, Eurostat, a Luxembourg-based government agency, reported that in 2024, EU exports of medicinal and pharmaceutical products rose by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). Meanwhile, imports increased only slightly by 0.5%, totaling $112.7 billion (€119.7 billion). Therefore, the rise in pharmaceutical production is driving the growth of the industrial microbiology market.

Major companies operating in the industrial microbiology market are concentrating on developing innovative solutions, such as rapid microbial screening technologies, to speed up quality control processes and enhance operational efficiency. Rapid microbial screening technologies allow quicker detection of microbial contamination, minimizing product hold times and enabling high-throughput testing to improve productivity and product safety. For example, in October 2023, Hygiena, a US-based food safety diagnostics company, introduced the RapiScreen Beverage Kit, an advanced microbial screening solution designed for industrial microbiology applications in the beverage industry. The RapiScreen Beverage Kit employs ATP bioluminescence technology to rapidly identify microbial contamination in low-pH beverages, including fruit juices, teas, energy drinks, UHT-pasteurized products, and smoothie mixes. It provides quality control results in less than 30 minutes following a brief incubation period, compared with conventional culture methods that may require 4-10 days, and supports the testing of up to 96 samples at once, enabling quicker product release, lower storage costs, better inventory turnover, and improved safety and profitability in manufacturing operations.

In January 2024, Novozymes A/S, a Denmark-based biotechnology company, merged with Chr. Hansen Holding A/S to form Novonesis, a global biosolutions partner. Through this merger, Novozymes and Chr. Hansen established Novonesis as a leading global biosolutions organization focused on utilizing microbiology and biology-based innovations to support sustainable growth, improve business performance, and generate positive outcomes for people and the planet. Chr. Hansen Holding A/S is a Denmark-based biotechnology company.

Major companies operating in the industrial microbiology market include Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., The Merck Group, Becton Dickinson and Company, Asiagel Corporation, Eppendorf Group, bioMerieux SA, Novamed Ltd., QIAGEN N.V., Sartorius AG, 3M Company, Agilent Technologies Inc., vermicon AG, Eurofins Scientific SE, MilliporeSigma, Hardy Diagnostics, Neogen Corporation, HiMedia Laboratories, BioConnections, Biomerica Inc., Bruker Corporation, Charles River Laboratories International Inc., GENEWIZ Inc., Luminex Corporation, Microbiologics Inc., Promega Corporation, Q Laboratories Inc., Rapid Micro Biosystems Inc., Shimadzu Corporation, TSI Incorporated

North America was the largest region in the industrial microbiology market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global industrial microbiology market report during the forecast period. The regions covered in the industrial microbiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the industrial microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The industrial microbiology market consists of revenues earned by entities by providing services such as production hygiene and final product testing, preservation system design and evaluation, testing and validation of disinfectants and treated articles, and efficacy data generation for product registration. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial microbiology market also includes sales of slides, test tubes, petri dishes, solid and liquid growth mediums, inoculation loops, pipettes and tips, incubators, autoclaves, and laminar flow hoods, which are used in providing industrial microbiology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Industrial Microbiology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses industrial microbiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for industrial microbiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The industrial microbiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Equipment And Systems; Reaction Consumables; Laboratory Supplies
• 2) By Test: Sterility Testing; Microbial Limits Testing; Bio-Burden Testing; Water And Environmental Testing
• 3) By End-Use: Food And Beverages; Pharmaceutical Biotechnology; Agricultural; Environmental; Cosmetic And Personal Care; Other End-Uses
• Subsegments:
• 1) By Equipment And Systems: Incubators; Autoclaves; Microbial Analyzers; Sterilizers; Automated Systems
• 2) By Reaction Consumables: Culture Media; Reagents and Chemicals; Growth Supplements
• 3) By Laboratory Supplies: Petri Dishes; Test Tubes; Pipettes; Filters; Gloves And Personal Protective Equipment (PPE)
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Bio-Rad Laboratories Inc.; The Merck Group; Becton Dickinson and Company; Eppendorf Group; bioMerieux SA; QIAGEN N.V.; Sartorius AG; 3M Company; Agilent Technologies Inc.; vermicon AG; Eurofins Scientific SE; MilliporeSigma; Hardy Diagnostics; Neogen Corporation; HiMedia Laboratories; Biomerica Inc.; Bruker Corporation; Charles River Laboratories International Inc.; GENEWIZ Inc.; Luminex Corporation; Microbiologics Inc.; Promega Corporation; Q Laboratories Inc.; Rapid Micro Biosystems Inc.; Shimadzu Corporation; TSI Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.